Your search returned 4 results.

Sort
Results
1.
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. MedStar authors:
  • Priebat, Dennis A
PMID:
  • 28988646
Year: 2017
Citation:
  • Lancet Oncology. 18(11):1493-1501, 2017 Nov
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Attia S, Baker LH, Bolejack V, Burgess M, Butterfield LH, Crowley J, D'Angelo S, Davis LE, Hu J, Lazar AJ, Maki RG, Movva S, Okuno SH, Patel S, Priebat DA, Reed DR, Reinke D, Riedel RF, Rodriguez-Canales J, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wistuba II
2.
Adjuvant therapy for high-grade, uterus-limited leiomyosarcoma: results of a phase 2 trial (SARC 005). MedStar authors:
  • Priebat, Dennis A
PMID:
  • 23335221
Citation:
  • Cancer. 119(8):1555-61, 2013 Apr 15.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Clinical Trial, Phase II
  • Journal Article
  • Multicenter Study
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Araujo DM, Baker LH, George S, Hensley ML, Maki RG, Priebat DA, Soslow RA, Sutton G, Wathen JK
3.
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. MedStar authors:
  • Priebat, Dennis A
PMID:
  • 31900276
Year: 2020
Citation:
  • Clinical Cancer Research. 26(6):1258-1266, 2020 03 15.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Attia S, Bolejack V, Burgess M, Davis LE, Hu J, Keung EZ, Lazar AJ, Movva S, Okuno S, Parra Cuentas E, Priebat DA, Reed DR, Reinke DK, Reuben A, Riedel RF, Rodrigues-Canales J, Roland CL, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wang WL, Wargo JA
4.
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033. MedStar authors:
  • Priebat, Dennis A
PMID:
  • 28196207
Year: 2017
Citation:
  • JAMA Oncology. , 2017 Feb 09
  • JAMA Oncology. 3(7):944-952, 2017 Jul 01
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Baker LH, Benjamin RS, Blackstein ME, Blanke CD, Borden EC, Corless CL, Crowley JJ, Demetri GD, Fletcher JA, Heinrich M, Maki RG, Owzar K, Priebat DA, Rankin C, Ryan CW, Tap WD, von Mehren M
Pages

Powered by Koha